Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates

PURPOSE: Within the last decade, SurePath and ThinPrep [both liquid-based cytology (LBC) tests] have replaced conventional cytology (CC) as primary test method in cervical cancer screening programs of multiple countries. The aim of our study was to examine the effect in the Dutch screening program....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Causes Control
Päätekijät: Rozemeijer, Kirsten, Penning, Corine, Siebers, Albert G., Naber, Steffie K., Matthijsse, Suzette M., van Ballegooijen, Marjolein, van Kemenade, Folkert J., de Kok, Inge M. C. M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2015
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4703623/
https://ncbi.nlm.nih.gov/pubmed/26458884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10552-015-0678-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia